EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    3.6.1.13 | Breast Neoplasms |
29343827 |
Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells. |
causal interaction
ongoing research
therapeutic application
unassigned |
4
1
4
0 |
| 3.6.1.13 | Breast Neoplasms |
31510016 |
Expression of Oncogenic Drivers in 3D Cell Culture Depends on Nuclear ATP Synthesis by NUDT5. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
3
4 |
| 3.6.1.13 | Breast Neoplasms |
31676755 |
Author Correction: Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells. |
causal interaction
therapeutic application
unassigned |
4
4
0 |
| 3.6.1.13 | Breast Neoplasms |
31902977 |
Molecular docking based virtual screening of the breast cancer target NUDT5. |
causal interaction
diagnostic usage
unassigned |
2
2
0 |
| 3.6.1.13 | Breast Neoplasms |
32300600 |
Identification of NUDT5 Inhibitors From Approved Drugs. |
causal interaction
therapeutic application
unassigned |
4
4
0 |
| 3.6.1.13 | Breast Neoplasms |
33276127 |
NUDT5 as a novel drug target and prognostic biomarker for ER-positive breast cancer. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
3
3
4
0 |
| 3.6.1.13 | Breast Neoplasms |
33571243 |
The high expression of NUDT5 indicates poor prognosis of breast cancer by modulating AKT / Cyclin D signaling. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
3
1 |
| 3.6.1.13 | Breast Neoplasms |
33668737 |
Role of the NUDT Enzymes in Breast Cancer. |
ongoing research
unassigned |
3
0 |
| 3.6.1.13 | Carcinogenesis |
33096144 |
The high expression of MTH1 and NUDT5 promotes tumor metastasis and indicates a poor prognosis in patients with non-small-cell lung cancer. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
2
4 |
| 3.6.1.13 | Carcinoma |
32518727 |
The high expression of MTH1 and NUDT5 predict a poor survival and are associated with malignancy of esophageal squamous cell carcinoma. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
4
1 |
